Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.

Medications originally designed to manage Type 2 diabetes and help with weight loss—like Ozempic and Mounjaro—may also have the power to blunt something far more insidious: cravings for drugs ...

Brooks Nader risked an awkward-run in with her former flame Tom Brady while in Venice, Italy for Jeff Bezos and Lauren Sanchez 's wedding. This week, the 28-year-old model shared a photo of her ...

Weight loss drug Ozempic may also reduce the risk of dementia, suggests a new study. American researchers found that semaglutide - the active ingredient in Ozempic and another weight loss ...

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

Novo Nordisk has also filed for a label expansion of Ozempic in the US, and a decision is expected in last quarter of 2025.

Michael Rubin and Rene Mendoza, Latham & Watkins are among the recipients of the The Recorder's 2025 Vanguard Award. Read a Q&A with them below.

June 23, 2025 Rubin’s First Snapshots Launch a Decade of Discovery Scientists and engineers at CMU's McWilliams Center for Cosmology and Astrophysics are building tools to aid astronomers around the ...

Wegovy and Ozempic are costly and have been driving up Medi-Cal spending. The governor's office says scaling back coverage for these drugs would save the state up to $680 million by 2029.

In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

Fanatics CEO Michael Rubin sat down with Rich Kleiman of BOARDROOM for a Q&A on a wide range of topics, including their trading card and collectibles business along with their betting and gaming ...